High quality of 58-month life in lung cancer patient with brain metastases sequentially treated with gefitinib and osimertinib

por Zhang Ying, Zhang Xiaowen, Wang Fang, Feng Yan, Tang Huaping
Publicado 2021

Comparing survival and treatment response of patients with acquired T790M mutation second‐line osimertinib versus sequential treatment of chemotherapy followed by osimertinib: A re...

por Chin‐Chou Wang, Chien‐Hao Lai, Yu‐Ping Chang, Huang‐Chih Chang, Chia‐Cheng Tseng, Kuo‐Tung Huang, Meng‐Chih Lin
Publicado 2021

Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy

por Santarpia M, Liguori A, Karachaliou N, Gonzalez-Cao M, Daffinà MG, D'Aveni A, Marabello G, Altavilla G, Rosell R
Publicado 2017